Jonathan M. Nathan

Jonathan M. Nathan serves as senior counsel in the Corporate and Securities Group. His practice focuses on securities and corporate finance, corporate governance, mergers and acquisitions, and corporate transactional matters. Jonathan frequently represents issuers and underwriters in public and private equity and debt offerings, investors and companies in venture capital and private equity transactions, and acquirers and targets in M&A deals. He has broad experience in advising U.S. and Israeli clients on disclosure, regulatory and compliance issues related to public reporting status under the rules of the U.S. Securities and Exchange Commission and NASDAQ. He counsels companies in all stages of the corporate growth cycle, from early stage private companies to large, publicly traded companies.
Prior to moving to Israel and joining Meitar in the fall of 2008, Jonathan practiced in the corporate and securities, and capital markets, groups of large New York law firms for six years, spending his final three years at Reed Smith LLP.
Jonathan received his J.D. degree in 2002 from NYU School of Law, where he served as Senior Articles Editor of the Journal of International Law and Politics, and his B.A. degree in Biology and Religion, cum laude, from Columbia University in 1998.

Representative experience:

• Representation of Talecris Biotherapeutics Holdings Corp. (formerly NASDAQ: TLCR) in its $950 million initial public offering and listing on the NASDAQ Global Select Market.
• Representation of Volcano Corp. (NASDAQ:VOLC) in its $54 million initial public offering and listing on the NASDAQ Global Market.
• Representation of the underwriters in the $1.5 billion senior notes offering by Teva Pharmaceuticals Industries Ltd (NASDAQ and TASE: TEVA).
• Representation of Compugen Ltd. (NASDAQ and TASE: CGEN) in its $20 million Controlled Equity Offering.
• Representation of the Alpha Group investors in their tender offer to purchase up to a 7.6% equity interest in Retalix Ltd. (NASDAQ GS and TASE: RTLX) for up to $14.1 million.
• Representation of Africa-Israel Investments Ltd. in its acquisition of an approximate 10% equity stake in Alon USA Energy, Inc. (NYSE: ALJ).
• Representation of Fundtech Ltd. (formerly NASDAQ GS and TASE: FNDT) in its sale to private equity firm GTCR for $390 million.
• Representation of the Viola Private Equity Fund in its acquisition of a 20% equity stake in Orad Hi-Tec Systems (Frankfurt: OHT) for $5.9 million.  
• Representation of numerous Israeli public companies in their ongoing reporting with the SEC under the U.S. Securities Exchange Act of 1934, and in their registration of shares under the U.S. Securities Act of 1933 and the listing of such shares for trading on NASDAQ.
• Representation of EK Success Ltd., a leading provider of scrapbooking and paper-based craft products, in its sale to private equity firm GTCR.
• Representation of Gizmoz, a company specializing in personalized and portable avatars, in its merger with DAZ 3D.
• Representation of LM Partners L.P. of Viola Partners (formerly, the Dovrat Group) and Ofer Hi-Tech in their $150 million private placement in Lumenis Ltd., a provider of laser machines for various medical and aesthetic purposes.